Stanol Ester

Raisio CEO Matti Rihko: “All in all a good performance...

Competition remains fierce in cholesterol-lowering niche

Benecol buy-back boosts Raisio Q2 results

By Shane STARLING

Sales and profits were up in Q2 at Raisio, with CEO of the €500m Finnish agro-food player Matti Rihko content its re-housing of key brand Benecol was paying off.

“This expansion to the world's most populated country supports Raisio’s aim to open up new markets for Benecol products together with its licensing partners...

Benecol enters China

By Shane STARLING

Finnish food-agriculture giant Raisio has launched its cholesterol-lowering, plant stanol-based Benecol brand in China in a powder form via mostly medical channels in its big coastal cities.

'On our terms': Raisio resumes global control of Benecol

“This is a good move for Raisio. They are the correct parent of this niche brand.”

Raisio brings cholesterol-lowering Benecol home for €90m

By Shane STARLING

“J&J should have sold it 10 years ago,” is one analyst’s appraisal of Finnish agro-food giant Raisio’s buy-back of the licensing rights to its cholesterol lowering, plant stanol-based Benecol brand today, referring to US market difficulties for the...